News & Updates
Filter by Specialty:

IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients
All intravenous (IV) and subcutaneous (SC) doses of the monoclonal antibody combination of casirivimab plus imdevimab effectively reduces viral load in COVID-19 patients with asymptomatic or low-risk symptomatic infection, according to the results of a phase II study.
IV, SC doses of biologic combo effective in asymptomatic, low-risk COVID-19 patients
07 Sep 2022
Dietary cholesterol consumption may lead to subsequent type 2 diabetes
There appears to be a positive dose-response association between dietary cholesterol and type 2 diabetes mellitus (T2DM), where the higher the intake, the greater the incidence of T2DM especially in Western countries, according to a study.
Dietary cholesterol consumption may lead to subsequent type 2 diabetes
07 Sep 2022
Topical combination, physical treatments best for mild-to-moderate acne
Topical pharmacological treatment combinations, chemical peels, and photochemical therapy are deemed to be the best and the most effective options for mild-to-moderate acne vulgaris.
Topical combination, physical treatments best for mild-to-moderate acne
06 Sep 2022
Regular coffee intake ups risk of primary open-angle glaucoma
Genetic evidence from a recent study suggests that habitual coffee drinkers have an increased risk of primary open-angle glaucoma (POAG).